EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 110 filers reported holding EPIZYME INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $18,858,000 | -15.1% | 1,779,094 | +8.5% | 0.68% | -13.3% |
Q2 2018 | $22,208,000 | +30.2% | 1,639,000 | +70.6% | 0.78% | +32.0% |
Q1 2018 | $17,057,000 | +34.6% | 960,970 | -4.8% | 0.59% | +18.4% |
Q4 2017 | $12,670,000 | -5.1% | 1,009,526 | +44.1% | 0.50% | -17.0% |
Q3 2017 | $13,345,000 | +33.4% | 700,526 | +5.8% | 0.60% | +12.5% |
Q2 2017 | $10,002,000 | -58.7% | 662,369 | -53.1% | 0.53% | -42.9% |
Q1 2017 | $24,243,000 | +25.1% | 1,413,596 | -11.7% | 0.94% | +17.3% |
Q4 2016 | $19,373,000 | +576.2% | 1,601,049 | +449.9% | 0.80% | +499.2% |
Q3 2016 | $2,865,000 | -55.0% | 291,179 | -53.2% | 0.13% | -46.8% |
Q2 2016 | $6,372,000 | – | 622,299 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |